FR2548899B1 - Produit medicamenteux contenant de l'acetate de (1,1-dimethyl-3-oxopyrazolidine-1-io-4-yl) pour la therapie de la maladie hypertensive et de l'infarctus du myocarde - Google Patents

Produit medicamenteux contenant de l'acetate de (1,1-dimethyl-3-oxopyrazolidine-1-io-4-yl) pour la therapie de la maladie hypertensive et de l'infarctus du myocarde

Info

Publication number
FR2548899B1
FR2548899B1 FR8407799A FR8407799A FR2548899B1 FR 2548899 B1 FR2548899 B1 FR 2548899B1 FR 8407799 A FR8407799 A FR 8407799A FR 8407799 A FR8407799 A FR 8407799A FR 2548899 B1 FR2548899 B1 FR 2548899B1
Authority
FR
France
Prior art keywords
oxopyrazolidine
therapy
dimethyl
acetate
myocardial infarction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8407799A
Other languages
English (en)
French (fr)
Other versions
FR2548899A1 (fr
Inventor
Ivars Yanovich Kalvinsh
Marina Lvovna Erenshtein
Gunar Arvidovich Bremanis
Valdis Danielovich Mikazhan
Maris Margerovich Veveris
Edmund Yanovich Lukevits
Edit Ansovna Pule
Anatoly Savelievich Birman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST ORGANICHESKOGO SINTEZA AK
Original Assignee
INST ORGANICHESKOGO SINTEZA AK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST ORGANICHESKOGO SINTEZA AK filed Critical INST ORGANICHESKOGO SINTEZA AK
Publication of FR2548899A1 publication Critical patent/FR2548899A1/fr
Application granted granted Critical
Publication of FR2548899B1 publication Critical patent/FR2548899B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8407799A 1983-05-18 1984-05-18 Produit medicamenteux contenant de l'acetate de (1,1-dimethyl-3-oxopyrazolidine-1-io-4-yl) pour la therapie de la maladie hypertensive et de l'infarctus du myocarde Expired FR2548899B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU3593392 1983-05-18

Publications (2)

Publication Number Publication Date
FR2548899A1 FR2548899A1 (fr) 1985-01-18
FR2548899B1 true FR2548899B1 (fr) 1989-01-06

Family

ID=21064187

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8407799A Expired FR2548899B1 (fr) 1983-05-18 1984-05-18 Produit medicamenteux contenant de l'acetate de (1,1-dimethyl-3-oxopyrazolidine-1-io-4-yl) pour la therapie de la maladie hypertensive et de l'infarctus du myocarde

Country Status (7)

Country Link
US (1) US4568689A (enExample)
JP (1) JPS59222416A (enExample)
CA (1) CA1229553A (enExample)
DE (1) DE3418651A1 (enExample)
FR (1) FR2548899B1 (enExample)
GB (1) GB2142533B (enExample)
IT (1) IT1196109B (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2319278C2 (de) * 1973-04-17 1986-02-20 Bayer Ag, 5090 Leverkusen Pharmazeutisches Mittel
US3974176A (en) * 1973-08-16 1976-08-10 Byk-Gulden Lomberg Chemische Fabrik Gmbh Halogen pyrazoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them
LU71847A1 (enExample) * 1975-02-14 1977-01-05
SU747855A1 (ru) * 1978-04-12 1980-07-15 Ташкентский Ордена Трудового Красного Знамени Медицинский Институт 3-Пиразолилметиловый эфир пропионовой кислоты, обладающий противовоспалительной активностью
GB2073740A (en) * 1980-03-03 1981-10-21 Wellcome Found Pyrazolidinones

Also Published As

Publication number Publication date
DE3418651A1 (de) 1984-11-22
DE3418651C2 (enExample) 1987-11-05
GB2142533B (en) 1987-03-04
IT1196109B (it) 1988-11-10
CA1229553A (en) 1987-11-24
GB8412342D0 (en) 1984-06-20
US4568689A (en) 1986-02-04
JPS59222416A (ja) 1984-12-14
IT8420949A0 (it) 1984-05-16
IT8420949A1 (it) 1985-11-16
FR2548899A1 (fr) 1985-01-18
GB2142533A (en) 1985-01-23

Similar Documents

Publication Publication Date Title
PT78340A (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
BE896986A (fr) Derives d'indole, procedes pour leur preparation et composition pharmaceutiques les contenant
FR2595351B1 (fr) Derives d'indole, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2665898B1 (fr) Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
HUT43808A (en) Process for production of new derivatives of n-/2'-aminphenil/-benzamid and medical preparatives containing thereof as active substance
FR2636628B1 (fr) Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
FR2574793B1 (fr) Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation
PT86635A (pt) Process for the preparation of novel 4-aryl-n-]2-(dialkylamino and heterocyclicamino)-alkyl"-1-piperazinecarboxamides and of pharmaceutical compositions containing the same
PH24326A (en) Substituted 3,4-dihydro-2h-benzopyrans,pharmaceutical compositions containing same and method of use thereof
FR2607502B1 (fr) Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant
FR2628973B1 (fr) Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition
PT78275A (fr) Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant
FR2533919B1 (fr) Derives a activite biologique de la 2,5-piperazinedione, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2635461B1 (fr) Utilisation de derives tricycliques pour l'obtention de medicaments destines au traitement du stress
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2636630B1 (fr) Nouveaux composes benzofuranniques, leur procede de preparation, compositions pharmaceutiques et cosmetique les contenant et utilisation de ces compositions
FR2548899B1 (fr) Produit medicamenteux contenant de l'acetate de (1,1-dimethyl-3-oxopyrazolidine-1-io-4-yl) pour la therapie de la maladie hypertensive et de l'infarctus du myocarde
MA24214A1 (fr) Procede pour la preparation de nouveaux composes et pour la preparation de compositions pharmaceutiques les contenant
FR2529551B1 (fr) Derives d'eburnane-oxime, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2622194B1 (fr) Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant
FR2751332B1 (fr) Derives d'oxopyrrolopyrrole, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2592043B1 (fr) 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo-(d, g) (1, 3, 6)-dioxazocines optiquement actives, procede pour leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse